» Articles » PMID: 16612980

The Cerebral Beta-amyloid Angiopathies: Hereditary and Sporadic

Overview
Journal Brain Pathol
Date 2006 Apr 15
PMID 16612980
Citations 88
Authors
Affiliations
Soon will be listed here.
Abstract

We review the clinical, radiologic, and neuropathologic features of the hereditary and sporadic forms of cerebral amyloid angiopathy (CAA) associated with vascular deposition of the beta-amyloid peptide. Amino acid substitutions at 4 sites in the beta-amyloid precursor protein, all situated within the beta-amyloid peptide sequence itself, have been shown to cause heritable forms of CAA. The vascular diseases caused by these mutations are associated primarily with cerebral hemorrhages, white matter lesions, and cognitive impairment, and only variable extents of the plaque and neurofibrillary pathologies characteristic of Alzheimer disease. Sporadic CAA typically presents 20 or more years later than hereditary CAA, but is otherwise characterized by a comparable constellation of recurrent cerebral hemorrhages, white matter lesions, and cognitive impairment. The clinical, radiologic and pathologic similarities between hereditary and sporadic CAA suggest that important lessons for this common age-related process can be learned from the mechanisms by which mutation makes beta-amyloid tropic or toxic to vessels.

Citing Articles

Identification of isoAsp7-Aβ as a major Aβ variant in Alzheimer's disease, dementia with Lewy bodies and vascular dementia.

Schrempel S, Kottwitz A, Piechotta A, Gnoth K, Buschgens L, Hartlage-Rubsamen M Acta Neuropathol. 2024; 148(1):78.

PMID: 39625512 PMC: 11615120. DOI: 10.1007/s00401-024-02824-9.


Heterogeneity of factors associated with cognitive decline and cortical atrophy in early- versus late-onset Alzheimer's disease.

Cho J, Yoon C, Shin J, Seo H, Kim W, Na H Sci Rep. 2024; 14(1):20429.

PMID: 39227668 PMC: 11372067. DOI: 10.1038/s41598-024-71402-6.


E22G Aβ40 fibril structure and kinetics illuminate how Aβ40 rather than Aβ42 triggers familial Alzheimer's.

Tehrani M, Matsuda I, Yamagata A, Kodama Y, Matsunaga T, Sato M Nat Commun. 2024; 15(1):7045.

PMID: 39147751 PMC: 11327332. DOI: 10.1038/s41467-024-51294-w.


Sex differences in histopathological markers of cerebral amyloid angiopathy and related hemorrhage.

Koemans E, Perosa V, Freeze W, Lee H, Kozberg M, Coughlan G Int J Stroke. 2024; 19(8):947-956.

PMID: 38703035 PMC: 11408965. DOI: 10.1177/17474930241255276.


Cerebral Amyloid Angiopathy: An Undeniable Small Vessel Disease.

Wang L, Liu Q, Yue D, Liu J, Fu Y J Stroke. 2024; 26(1):1-12.

PMID: 38326703 PMC: 10850457. DOI: 10.5853/jos.2023.01942.


References
1.
Nilsberth C, Westlind-Danielsson A, Eckman C, Condron M, Axelman K, Forsell C . The 'Arctic' APP mutation (E693G) causes Alzheimer's disease by enhanced Abeta protofibril formation. Nat Neurosci. 2001; 4(9):887-93. DOI: 10.1038/nn0901-887. View

2.
Cras P, Van Harskamp F, Hendriks L, Ceuterick C, van Duijn C, Stefanko S . Presenile Alzheimer dementia characterized by amyloid angiopathy and large amyloid core type senile plaques in the APP 692Ala-->Gly mutation. Acta Neuropathol. 1998; 96(3):253-60. DOI: 10.1007/s004010050892. View

3.
Hendriks L, van Duijn C, Cras P, Cruts M, Van Hul W, Van Harskamp F . Presenile dementia and cerebral haemorrhage linked to a mutation at codon 692 of the beta-amyloid precursor protein gene. Nat Genet. 1992; 1(3):218-21. DOI: 10.1038/ng0692-218. View

4.
Davis J, Van Nostrand W . Enhanced pathologic properties of Dutch-type mutant amyloid beta-protein. Proc Natl Acad Sci U S A. 1996; 93(7):2996-3000. PMC: 39749. DOI: 10.1073/pnas.93.7.2996. View

5.
Lemere C, Blusztajn J, Yamaguchi H, Wisniewski T, Saido T, Selkoe D . Sequence of deposition of heterogeneous amyloid beta-peptides and APO E in Down syndrome: implications for initial events in amyloid plaque formation. Neurobiol Dis. 1996; 3(1):16-32. DOI: 10.1006/nbdi.1996.0003. View